These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8469325)

  • 1. T2 relaxation time in patients with Parkinson's disease.
    Antonini A; Leenders KL; Meier D; Oertel WH; Boesiger P; Anliker M
    Neurology; 1993 Apr; 43(4):697-700. PubMed ID: 8469325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical MRI for iron detection in Parkinson's disease.
    Rossi M; Ruottinen H; Soimakallio S; Elovaara I; Dastidar P
    Clin Imaging; 2013; 37(4):631-6. PubMed ID: 23522789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR detection of brain iron.
    Thomas LO; Boyko OB; Anthony DC; Burger PC
    AJNR Am J Neuroradiol; 1993; 14(5):1043-8. PubMed ID: 8237678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.
    Du G; Lewis MM; Shaffer ML; Chen H; Yang QX; Mailman RB; Huang X
    PLoS One; 2012; 7(4):e35397. PubMed ID: 22530017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.
    Gelman N; Gorell JM; Barker PB; Savage RM; Spickler EM; Windham JP; Knight RA
    Radiology; 1999 Mar; 210(3):759-67. PubMed ID: 10207479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.
    Graham JM; Paley MN; Grünewald RA; Hoggard N; Griffiths PD
    Brain; 2000 Dec; 123 Pt 12():2423-31. PubMed ID: 11099445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related differences in iron content of subcortical nuclei observed in vivo: a meta-analysis.
    Daugherty A; Raz N
    Neuroimage; 2013 Apr; 70():113-21. PubMed ID: 23277110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.
    Drayer BP; Olanow W; Burger P; Johnson GA; Herfkens R; Riederer S
    Radiology; 1986 May; 159(2):493-8. PubMed ID: 3961182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen.
    Schenker C; Meier D; Wichmann W; Boesiger P; Valavanis A
    Neuroradiology; 1993; 35(2):119-24. PubMed ID: 8433786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
    O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
    Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease.
    Shergill JK; Cammack R; Cooper CE; Cooper JM; Mann VM; Schapira AH
    Biochem Biophys Res Commun; 1996 Nov; 228(2):298-305. PubMed ID: 8920909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of iron deposition in Parkinson's disease using enhanced T2 star-weighted angiography.
    Ji S; Zhang S; Mao Z; Han H; Yang Q; Zhu W; Zhu S; Xue Z
    Neurol India; 2016; 64(3):428-35. PubMed ID: 27147149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.
    Lisanby SH; McDonald WM; Massey EW; Doraiswamy PM; Rozear M; Boyko OB; Krishnan KR; Nemeroff C
    J Neural Transm Suppl; 1993; 40():13-21. PubMed ID: 8294897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.
    Jesse S; Kassubek J; Müller HP; Ludolph AC; Unrath A
    BMC Neurol; 2012 Dec; 12():163. PubMed ID: 23273141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.